跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ZEPOSIA CAPSULES 0.23MG AND 0.46MG (TREATMENT INITIATION PACK) - PPB Drug Approval Details
Approvals
/
PPB
/
ZEPOSIA CAPSULES 0.23MG AND 0.46MG (TREATMENT INITIATION PACK)
Approved
STANDARD
ZEPOSIA CAPSULES 0.23MG AND 0.46MG (TREATMENT INITIATION PACK)
BRISTOL-MYERS SQUIBB PHARMA (HK) LTD
🇰🇪 Pharmacy and Poisons Board
Approval Date
Jun 21, 2024
Approval ID
649d65077ba61844
Company
BRISTOL-MYERS SQUIBB PHARMA (HK) LTD
Type
Standard
Approval Details
Approval Id
649d65077ba61844
Product Name
ZEPOSIA CAPSULES 0.23MG AND 0.46MG (TREATMENT INITIATION PACK)
Drug Hk Name
ZEPOSIA CAPSULES 0.23MG AND 0.46MG (TREATMENT INITIATION PACK)
Registration Code
HK-67126
Company Name
BRISTOL-MYERS SQUIBB PHARMA (HK) LTD
Company Detail Path
/organization/bristol-myers-squibb-pharma-company
Registration Category
Part 1, Schedule 1 & Schedule 3 Poison
Sale Requirement
Prescription only Medicines
Registration Date
2021-06-28
Company Address
RM 3001-3002 30/F, WINDSOR HOUSE, 311, GLOUCESTER RD., CAUSEWAY BAY, HONG KONG
Active Ingredients
Approved
Quick Info
Agency
PPB
Country
🇰🇪
Approval Date
Jun 21, 2024
Approval ID
649d65077ba61844
Type
Standard
Back to PPB Approvals